Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review
The hallmarks of type 2 diabetes (T2D) include peripheral insulin resistance and insulin insufficiency. Given the significance of T2D as a major public health concern, the goal of this review article is to highlight the role of bioactive properties of soybeans in the prevention, control,...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academia.edu Journals
2024-03-01
|
| Series: | Academia Biology |
| Online Access: | https://www.academia.edu/115649078/Bioactive_molecules_from_soybeans_Glycine_max_with_anti_type_2_diabetes_activity_a_systematic_review |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823857109046919168 |
|---|---|
| author | Adekunle Babajide Rowaiye Lorretha Chinonye Emenyonu Ezinne Janefrances Nwonu Okiemute Ajiroghene Okpalefe Joseph Akwoba Ogugua Victor Oluwatoyin Akinseye Gordon Chukwuma Ibeanu |
| author_facet | Adekunle Babajide Rowaiye Lorretha Chinonye Emenyonu Ezinne Janefrances Nwonu Okiemute Ajiroghene Okpalefe Joseph Akwoba Ogugua Victor Oluwatoyin Akinseye Gordon Chukwuma Ibeanu |
| author_sort | Adekunle Babajide Rowaiye |
| collection | DOAJ |
| description |
The hallmarks of type 2 diabetes (T2D) include peripheral insulin resistance and insulin insufficiency. Given the significance of T2D as a major public health concern, the goal of this review article is to highlight the role of bioactive properties of soybeans in the prevention, control, and management of the disease. This study examined how bioactive molecules from soybeans modulate key enzymes that affect T2D. A systematic search of electronic databases such as PubMed and Google Scholar was conducted to find relevant original studies or non-original peer-reviewed papers published on the subject. Keyword combinations such as “Soy OR soybeans”, “Soybeans AND anti-inflammatory”, “Soybeans AND anti-oxidative”, and “Soybeans AND antidiabetic” were used in the search. A search was also conducted on all the key enzymes and bioactive molecules mentioned in the review. A total of 194 articles published in English were selected. Both in vivo and in vitro experiments, and human clinical trials have proven a marked efficacy of these bioactive molecules in suppressing the key enzyme biomarkers that modulate T2D pathogenesis. Based on empirical research, the consumption of soybean products and ingredients is associated with a lower incidence of T2D. These findings will contribute to the present understanding of the therapeutic potential of soy-derived compounds. However, this study does not capture the individual variances to these biomolecules; hence, there is the need for more future pharmacokinetic studies to better understand potential interactions, safety, and more efficacy concerns. |
| format | Article |
| id | doaj-art-0bb23c4de9d445a0a45df223d7fa2296 |
| institution | Kabale University |
| issn | 2837-4010 |
| language | English |
| publishDate | 2024-03-01 |
| publisher | Academia.edu Journals |
| record_format | Article |
| series | Academia Biology |
| spelling | doaj-art-0bb23c4de9d445a0a45df223d7fa22962025-02-11T23:54:17ZengAcademia.edu JournalsAcademia Biology2837-40102024-03-012110.20935/AcadBiol6177Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic reviewAdekunle Babajide Rowaiye0Lorretha Chinonye Emenyonu1Ezinne Janefrances Nwonu2Okiemute Ajiroghene Okpalefe3Joseph Akwoba Ogugua4Victor Oluwatoyin Akinseye5Gordon Chukwuma Ibeanu6Agricultural Biotechnology Department, National Biotechnology Development Agency, Abuja, 900107, Nigeria.Bioresources Development Centre Owode, National Biotechnology Development Agency, Abuja, 900107, Nigeria.Medical Biotechnology Department, National Biotechnology Development Agency, Abuja, 900107, Nigeria.Department of Genetics, Genomics and Bioinformatics, National Biotechnology Development Agency, Abuja, 900107, Nigeria.Department of Veterinary Public Health and Preventive Medicine, University of Nigeria, Nsukka, Enugu, 410001, Nigeria.Department of Chemical Sciences, Augustine University, Lagos, 106103, Nigeria.Department of Pharmaceutical Sciences, North Carolina Central University, Durham, NC, 27707, USA. The hallmarks of type 2 diabetes (T2D) include peripheral insulin resistance and insulin insufficiency. Given the significance of T2D as a major public health concern, the goal of this review article is to highlight the role of bioactive properties of soybeans in the prevention, control, and management of the disease. This study examined how bioactive molecules from soybeans modulate key enzymes that affect T2D. A systematic search of electronic databases such as PubMed and Google Scholar was conducted to find relevant original studies or non-original peer-reviewed papers published on the subject. Keyword combinations such as “Soy OR soybeans”, “Soybeans AND anti-inflammatory”, “Soybeans AND anti-oxidative”, and “Soybeans AND antidiabetic” were used in the search. A search was also conducted on all the key enzymes and bioactive molecules mentioned in the review. A total of 194 articles published in English were selected. Both in vivo and in vitro experiments, and human clinical trials have proven a marked efficacy of these bioactive molecules in suppressing the key enzyme biomarkers that modulate T2D pathogenesis. Based on empirical research, the consumption of soybean products and ingredients is associated with a lower incidence of T2D. These findings will contribute to the present understanding of the therapeutic potential of soy-derived compounds. However, this study does not capture the individual variances to these biomolecules; hence, there is the need for more future pharmacokinetic studies to better understand potential interactions, safety, and more efficacy concerns.https://www.academia.edu/115649078/Bioactive_molecules_from_soybeans_Glycine_max_with_anti_type_2_diabetes_activity_a_systematic_review |
| spellingShingle | Adekunle Babajide Rowaiye Lorretha Chinonye Emenyonu Ezinne Janefrances Nwonu Okiemute Ajiroghene Okpalefe Joseph Akwoba Ogugua Victor Oluwatoyin Akinseye Gordon Chukwuma Ibeanu Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review Academia Biology |
| title | Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review |
| title_full | Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review |
| title_fullStr | Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review |
| title_full_unstemmed | Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review |
| title_short | Bioactive molecules from soybeans (Glycine max) with anti-type 2 diabetes activity: a systematic review |
| title_sort | bioactive molecules from soybeans glycine max with anti type 2 diabetes activity a systematic review |
| url | https://www.academia.edu/115649078/Bioactive_molecules_from_soybeans_Glycine_max_with_anti_type_2_diabetes_activity_a_systematic_review |
| work_keys_str_mv | AT adekunlebabajiderowaiye bioactivemoleculesfromsoybeansglycinemaxwithantitype2diabetesactivityasystematicreview AT lorrethachinonyeemenyonu bioactivemoleculesfromsoybeansglycinemaxwithantitype2diabetesactivityasystematicreview AT ezinnejanefrancesnwonu bioactivemoleculesfromsoybeansglycinemaxwithantitype2diabetesactivityasystematicreview AT okiemuteajirogheneokpalefe bioactivemoleculesfromsoybeansglycinemaxwithantitype2diabetesactivityasystematicreview AT josephakwobaogugua bioactivemoleculesfromsoybeansglycinemaxwithantitype2diabetesactivityasystematicreview AT victoroluwatoyinakinseye bioactivemoleculesfromsoybeansglycinemaxwithantitype2diabetesactivityasystematicreview AT gordonchukwumaibeanu bioactivemoleculesfromsoybeansglycinemaxwithantitype2diabetesactivityasystematicreview |